Evidence map›Paper›PMID 42203767›Full record

ArticleCell death & disease2026

NF-κB inducing kinase (NIK) deletion accelerates KRAS-driven pancreatic cancer in association with tumor microenvironment remodeling.

Ziwei Du, Ulrike F G Büttner, Hannah Lea Wirth, Melanie Gerstenlauer, Uta Manfras, Rikarda Loidl, Doğa Bahçeci, Katja Steiger, Thomas Metzler, Lap Kwan Chan and 2 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ziwei DuInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Ulrike F G BüttnerInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Hannah Lea WirthInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Melanie GerstenlauerInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Uta ManfrasInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Rikarda LoidlInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Doğa BahçeciInstitute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany.
Katja SteigerInstitute of Pathology, Technical University Munich, Munich, Bayern, Germany.ORCID http://orcid.org/0000-0002-7269-5433
Thomas MetzlerInstitute of Pathology, Technical University Munich, Munich, Bayern, Germany.
Lap Kwan ChanDepartment of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
Miltiadis Tsesmelis *Single-Cell Sequencing Unit, University of Ulm, Ulm, Baden-Württemberg, Germany. miltiadis.tsesmelis@uni-ulm.de.ORCID http://orcid.org/0000-0002-7438-580X
Thomas Wirth *Institute of Physiological Chemistry, University of Ulm, Ulm, Baden-Württemberg, Germany. thomas.wirth@uni-ulm.de.ORCID http://orcid.org/0000-0003-4539-9054

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 288342734
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer marked by dense stroma, immune suppression, and therapy resistance. While canonical NF-κB signaling has been extensively studied in PDAC, the non-canonical pathway and its key kinase, NF-κB-inducing kinase (NIK), remain less characterized. Here, we employed genetically engineered mouse models, including Pdx1-Cre; KRAS

Indexed as

Carcinoma, Pancreatic DuctalGene DeletionPancreatic NeoplasmsProtein Serine-Threonine KinasesProto-Oncogene Proteins p21(ras)Tumor MicroenvironmentAnimalsCeruletideHumansMiceNF-kappa BNF-kappaB-Inducing KinasePancreatitisSignal TransductionCeruletideNF-kappa BNF-kappaB-Inducing KinaseProtein Serine-Threonine KinasesProto-Oncogene Proteins p21(ras)

Identifiers

PMID42203767
PMCPMC13216544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.